breast cancer

BioMarin's cancer drug success prompts launch of pivotal trial

BioMarin's cancer drug success prompts launch of pivotal trial

Reuters

Longer use of tamoxifen shown to cut risk of breast cancer recurrence

Longer use of tamoxifen shown to cut risk of breast cancer recurrence

Reuters

CTI Reports Final Results from Cooperative Group and NCI-Sponsored Trial of Brostallicin in Patients with Metastatic Triple-Negative Breast Cancer

CTI Reports Final Results from Cooperative Group and NCI-Sponsored Trial of Brostallicin in Patients with Metastatic Triple-Negative Breast Cancer

Yahoo/PR Newswire

BioMarin Gains on Prospects for Experimental Cancer Drug

BioMarin Gains on Prospects for Experimental Cancer Drug

Bloomberg

Merrimack completes enrollement in a Phase 2 study of MM-121 with Sanofi

Merrimack completes enrollement in a Phase 2 study of MM-121 with Sanofi

The Fly on the Wall

Puma Biotech Gains After Rival Drug Data Show No Threat

Puma Biotech Gains After Rival Drug Data Show No Threat

Bloomberg

Netupitant Results Could Roil Tesaro In May

Netupitant Results Could Roil Tesaro In May

Seeking Alpha

3 Biotechs Targeting Breast Cancer

3 Biotechs Targeting Breast Cancer

Seeking Alpha

Supreme Court To Hear Case That May Reshape Biopharma Research

Supreme Court To Hear Case That May Reshape Biopharma Research

Pharmalot

Pfizer's New Breast Cancer Drug Could Be A Game Changer

Pfizer's New Breast Cancer Drug Could Be A Game Changer

Seeking Alpha